Primary cutaneous anaplastic large cell lymphoma with fatal leukemic outcome in association with CLA and CCR4-negative conversion

Journal of the American Academy of Dermatology

Volumn 57, Issue 5 SUPPL., 2007, Pages

  Tokura, Yoshiki ^a   Sugita, Kazunari ^a   Yagi, Hiroaki ^b   Shimauchi, Takatoshi ^a   Kabashima, Kenji ^a   Takigawa, Masahiro ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; METHYLPREDNISOLONE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; THERARUBICIN; UNCLASSIFIED DRUG; VINCRISTINE;

AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; ELECTRON THERAPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LARGE CELL LYMPHOMA; LYMPHOCYTE; MALE; MEDICAL EXAMINATION; MONOTHERAPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIODIAGNOSIS; SKIN BIOPSY; SKIN LYMPHOMA; SOUTHERN BLOTTING; STOMACH MUCOSA; TH2 CELL; TREATMENT OUTCOME; TUMOR CELL;

AGED; ANTIGENS, NEOPLASM; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA, LARGE-CELL; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; PHENOTYPE; RECEPTORS, CHEMOKINE; SKIN; SKIN NEOPLASMS;

EID: 35148899631     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.08.053     Document Type: Article

References (16)

1. Willemze R., and Meijer C.J. Primary cutaneous CD30-positive lymphoproliferative disorders. Hematol Oncol Clin North Am 17 (2003) 1319-1332
2. Kummer J.A., Vermeer M.H., Dukers D., Meijer C.J., and Willemze R. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 109 (1997) 636-640
3. Yagi H., Tokura Y., Furukawa F., and Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma. J Invest Dermatol 107 (1996) 827-832
4. Kempf W., Levi E., Kamarashev J., Kutzner H., Pfeifer W., Petrogiannis-Haliotis T., et al. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol 29 (2002) 295-300
5. Shiota M., Nakamura S., Ichinohasama R., Abe M., Akagi T., Takeshita M., et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 86 (1995) 1954-1960
6. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87 (1996) 3437-3441
7. Wood G.S., Hardman D.L., Boni R., Dummer R., Kim Y.H., Smoller B.R., et al. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 88 (1996) 1765-1770
8. Su L.D., Schnitzer B., Ross C.W., Vasef M., Mori S., Shiota M., et al. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol 24 (1997) 597-603
9. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
10. Shehan J.M., Kalaaji A.N., Markovic S.N., and Ahmed I. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. J Am Acad Dermatol 51 (2004) 103-110
11. Sugimoto H., Nakayama F., Yamauchi T., Tokura Y., Iwatsuki K., Takigawa M., et al. Ki-1+ cutaneous lymphoma. Gene rearrangement analysis of tumor cells in tissue and short-term culture of a patient. Arch Dermatol 124 (1988) 405-408
12. Curco N., Servitje O., Sais G., Moreno A., and Peyri J. Primary cutaneous CD30-positive large-cell lymphoma: a case with fatal outcome. J Am Acad Dermatol 31 (1994) 1067-1068
13. Fuhlbrigge R.C., Kieffer J.D., Armerding D., and Kupper T.S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389 (1997) 978-981
14. Ferenczi K., Fuhlbrigge R.C., Pinkus J., Pinkus G.S., and Kupper T.S. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119 (2002) 1405-1410
15. + adult T-cell leukemia cells. Clin Cancer Res 11 (2005) 2427-2435
16. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 (2005) 345-352